Various cancers show elevated levels of TACC3, including prostate cancer, hepatocellular carcinoma (HCC), non-small cell lung cancer and breast cancer. TACC3 is a TACC family member. It plays critical roles in protecting microtubule stability and centrosome integrity. Therefore, TACC3 seems a highly attractive therapeutic target. TACC3 inhibition in breast...